Redcare Pharmacy raises revenue guidance. What it means for Redcare Pharmacy stock
Published on 10/03/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 28, 2026, Redcare Pharmacy N.V. announced that it had raised its 2026 revenue guidance in a company update published through its investor-relations website. The company is the issuer identified with ISIN NL0012044747.
In separate market data, Redcare Pharmacy was at EUR 70.18 in weekend trading at Lang & Schwarz on October 3, 2026, at 11:16 a.m. CEST. The price was up EUR 0.10, or plus 0.14 percent, versus the EUR 70.08 close at Lang & Schwarz on October 2, 2026.
Weekend trading
The bid was EUR 69.80 and the ask was EUR 70.55 at the quoted time. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
Last Xetra trading day
The reference close was EUR 70.08 at Lang & Schwarz on October 2, 2026. The quote is stated separately from the company announcement dated September 28, 2026.
Revenue guidance update
Redcare Pharmacy’s investor-relations website lists the September 28, 2026 announcement as an update saying that the company raised its revenue guidance for 2026. The next Xetra session is scheduled for October 5, 2026.
